[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Book and Media Reviews
August 15, 2007

Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing

Author Affiliations
 

Book and Media Reviews Section Editor: John L. Zeller, MD, PhD, Contributing Editor.

JAMA. 2007;298(7):807-812. doi:10.1001/jama.298.7.811

Who could envision that the simple task of placing a pill on the tongue and swallowing it represents the culmination of a fierce battle involving industrialists, politicians, and third-world advocates?

In an increasingly acrimonious dialogue, vested interests on all sides of the pharmaceutical debate are finding themselves with an abundance of front-page headlines and empathetic tales of the woebegone: medications for treatment of human immunodeficiency virus are too expensive for African children. Research and development costs are further burdening United States–based pharmaceutical companies and driving up costs. Medicare Part D is questioning whether politics can play a role in drug price negotiation, as elderly individuals bemoan gaps in their prescription drug plans. Reimportation of less expensive drugs from Canada garners presidential comment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×